SA GENFIT financials
SA GENFIT
Country: FR Reporting currency: EUR Latest annual report: 2024-12-31
LEI:
969500XPWN2DMZQA5X73 Financial statements
(EUR, as reported — unscaled; 94 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €70.9M | €38.2M |
| Operating profit (EBIT) | €3.3M | -€26.6M |
| Net finance income / (cost) | -€1.4M | -€1.9M |
| Finance costs | €4.8M | €5.6M |
| Profit before tax | €1.8M | -€28.5M |
| Income tax expense | €340.0K | €380.0K |
| Profit for the year | €1.5M | -€28.9M |
| Total comprehensive income | -€272.0K | -€27.4M |
| Per share | ||
| Basic EPS | €0.03 | €-0.58 |
| Diluted EPS | €0.03 | €-0.58 |
| Free cash flow / share | €0.29 | €-1.12 |
| Cash flow statement | ||
| Net cash from operating activities | €15.5M | -€55.4M |
| Net cash from investing activities | -€1.0M | €2.2M |
| Purchase of PP&E (capex) | €979.0K | €414.0K |
| Purchase of intangibles | €0 | €2.1M |
| Net cash from financing activities | -€10.6M | -€5.1M |
| Proceeds from borrowings | €0 | €89.0K |
| Repayments of borrowings | €9.2M | €3.6M |
| Lease liability payments | €1.1M | €1.1M |
| Net change in cash | €3.9M | -€58.3M |
| Balance sheet | ||
| Total assets | €151.4M | €173.9M |
| Non-current assets | €58.7M | €60.8M |
| Property, plant & equipment | €7.6M | €7.9M |
| Current assets | €92.8M | €113.1M |
| Inventories | €4.0K | €4.0K |
| Trade & other receivables | €7.6M | €32.7M |
| Cash & equivalents | €81.8M | €77.8M |
| Total equity | €69.2M | €68.0M |
| Non-current liabilities | €7.0M | €67.4M |
| Current liabilities | €75.2M | €38.5M |
| Trade & other payables | €18.4M | €18.8M |
| Deferred tax liabilities | €145.0K | €455.0K |
| Derived metrics | ||
| Free cash flow | €14.6M | -€55.8M |
| Operating margin | 4.6% | -69.6% |
| Net margin | 2.1% | -75.7% |
| Return on equity | 2.2% | -42.5% |
| Cash conversion ratio | 10.32× | 1.92× |
| Capex coverage | 15.88× | -133.89× |
| Other reported items | ||
| Adjustments For Decrease Increase In Trade and Other Receivables | €24.0M | -€17.4M |
| Adjustments For Depreciation and Amortisation Expense | €1.7M | €1.7M |
| Adjustments For Finance Income Cost | -€346.0K | -€485.0K |
| Adjustments For Income Tax Expense | €340.0K | €380.0K |
| Adjustments For Increase Decrease In Trade and Other Payables | -€15.5M | -€10.4M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -€56.0K | -€81.0K |
| Adjustments For Sharebased Payments | €610.0K | €578.0K |
| Cash Flows From Used In Operations Before Changes In Working Capital | €7.2M | -€27.1M |
| Current Debt Instruments Issued | €54.6M | €415.0K |
| Current Deferred Income Other Than Current Contract Liabilities | €0 | €11.7M |
| Current Provisions | €40.0K | €40.0K |
| Current Tax Liabilities | €155.0K | €23.0K |
| Deferred Tax Assets | €0 | €0 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €60.0K | €80.0K |
| Equity and Liabilities | €151.4M | €173.9M |
| Expense of Restructuring Activities | €0 | -€505.0K |
| Finance Income | €3.3M | €3.7M |
| General and Administrative Expense | €19.5M | €17.7M |
| Income Taxes Paid Refund Classified As Operating Activities | €74.0K | €465.0K |
| Increase Decrease In Working Capital | -€8.4M | €27.8M |
| Increase Decrease Through Appropriation of Retained Earnings | €0 | €0 |
| Increase Decrease Through Sharebased Payment Transactions | €610.0K | €578.0K |
| Increase Decrease Through Transfers and Other Changes Equity | €1.0K | €227.0K |
| Increase Decrease Through Treasury Share Transactions | -€177.0K | €8.0K |
| Intangible Assets Other Than Goodwill | €48.0M | €48.8M |
| Interest Paid Classified As Financing Activities | €2.1M | €2.2M |
| Issued Capital | €12.5M | €12.5M |
| Noncurrent Debt Instruments Issued | €0 | €52.2M |
| Noncurrent Deferred Income Other Than Noncurrent Contract Liabilities | €0 | €3.8M |
| Noncurrent Provisions For Employee Benefits | €1.3M | €978.0K |
| Number of Shares Outstanding | 50.0M | 49.8M |
| Other Adjustments For Noncash Items | €2.5M | -€878.0K |
| Other Comprehensive Income | -€1.8M | €1.5M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -€649.0K | €2.3M |
| Other Comprehensive Income Net of Tax Gains Losses From Investments In Equity Instruments | -€923.0K | -€785.0K |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€207.0K | -€51.0K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Before Tax | -€649.0K | €2.3M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -€1.1M | -€836.0K |
| Other Current Financial Liabilities | €2.0M | €7.5M |
| Other Current Nonfinancial Assets | €3.4M | €2.6M |
| Other Noncurrent Financial Assets | €3.1M | €4.1M |
| Other Noncurrent Financial Liabilities | €5.6M | €10.0M |
| Other Operating Income Expense | -€316.0K | -€141.0K |
| Other Revenue | €3.9M | €9.6M |
| Proceeds From Issuing Shares | €61.0K | €0 |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €80.0K | €172.0K |
| Proceeds From Sales Or Maturity of Financial Instruments Classified As Investing Activities | €0 | €4.6M |
| Purchase of Financial Instruments Classified As Investing Activities | €140.0K | €12.0K |
| Purchase of Interests In Associates | €0 | €0 |
| Research and Development Expense | €47.2M | €46.5M |
| Reserve of Exchange Differences On Translation | €347.0K | €996.0K |
| Retained Earnings Excluding Profit Loss For Reporting Period | -€392.1M | -€361.9M |
| Retained Earnings Profit Loss For Reporting Period | €1.5M | -€28.9M |
| Revenue From Contracts With Customers | €67.0M | €28.6M |
| Sales and Marketing Expense | €634.0K | €876.0K |
| Share Premium | €446.9M | €445.3M |
Methodology
Every line item above is a fact tagged in SA GENFIT's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.